NORWALK, CT – Mederi Therapeutics Inc. today announced two milestones in the worldwide growth of Stretta Therapy for GERD, which include the completion of the 18,000th Stretta procedure and new regulatory approvals in OUS markets of Mexico, India, South Africa, Australia, Argentina and South Korea.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Pu7tUf
Cap comentari:
Publica un comentari a l'entrada